Dr. Benedikt Castellano

Headache specialist · National Cancer Center Tokyo · Japan (JP) · Neurology

Tier 1STK-0122GoodOwner MSL LOLuis Ortega

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Headache medicine
Disease interests: MIG
Scientific interests: CGRP persistenceChronic migraineSwitching
Engagement preference: Either
Advisory boards: 3
Publications: 64
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 1: 4 per year (assumption)

Last engaged: 22 Jul 2026 (55 days ago)
Next planned contact: 21 Oct 2026
Last 6 months vs target: 100%
2 of 2 expected engagements

Insights from this stakeholder (1)

INS-0037Drug interactions
18 Apr 2026 · Adherence and persistence
MediumClosed

Engagement history (3)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
22 Jul 2026	Scientific exchange	Virtual	Luis Ortega	Lumeva	Drug interactions	0	—	Reviewed	ENG-0213
17 Apr 2026	Scientific exchange	In person	Luis Ortega	Lumeva	Drug interactionsReal-world persistence	1	—	Reviewed	ENG-0212
08 Jan 2026	Congress meeting	Virtual	Luis Ortega	Lumeva	Dosing in hepatic impairmentChronic migraine data	0	—	Reviewed	ENG-0169

Timeline

22 Jul 2026
Scientific exchange
Drug interactions
17 Apr 2026
Scientific exchange
Drug interactions, Real-world persistence
08 Jan 2026
Congress meeting
Dosing in hepatic impairment, Chronic migraine data

Related stakeholders (4)

National Cancer Center Tokyo

Dr. Gabriel Ueda
Radiation oncologist
Tier 2
Dr. Sven Nakamura
Oncology pharmacist
Tier 1
Dr. Emiko Olsen
Oncology pharmacist
Tier 1
Dr. Yuki Sato
Primary care physician
Tier 2